for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Arch Biopartners Submits IND Application For Metablok

June 8 (Reuters) - Arch Biopartners Inc:

* ARCH BIOPARTNERS SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION TO THE FDA FOR METABLOK (LSALT PEPTIDE)

* ARCH BIOPARTNERS -SUBMITTED IND APPLICATION FOR METABLOK TO CONDUCT PHASE II TRIAL TO PREVENT ACUTE ORGAN INFLAMMATION, INJURY EXPERIENCED BY PATIENTS WITH COVID-19 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up